Excipients play a pivotal role in the field of biopharmaceutics, serving as essential components in drug formulations. These inert substances, often referred to as formulation aids, not only enhance the stability and bioavailability of active pharmaceutical ingredients (APIs) but also contribute to the overall safety and efficacy of pharmaceutical products.
In biopharmaceutics, excipients are carefully selected to facilitate drug absorption, distribution, metabolism, and excretion. They can influence drug release profiles, solubility, and permeability, playing a crucial role in optimizing the therapeutic performance of a formulation. Excipients also contribute to the physical and chemical stability of biopharmaceuticals, ensuring their integrity throughout the manufacturing, storage, and administration processes.
Furthermore, excipients may aid in overcoming formulation challenges, such as poor drug solubility or instability, ultimately improving the overall pharmacokinetics of the drug. As the field of biopharmaceutics continues to evolve, the strategic use of excipients remains integral to the development of innovative drug delivery systems, fostering advancements in therapeutic efficacy and patient outcomes.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Emerging formulation and delivery applications of Vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Antibody-proteases as translational tools of the next-step generation to be applied for biopharmacy-related and precision medical practice
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia